NEW HAVEN, Conn., March 11, 2009 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Michael D. Kishbauch, President and Chief Executive Officer, will give a corporate presentation at the upcoming Cowen & Company 29th Annual Healthcare Conference on Tuesday, March 17, 2009 at 11:00 a.m. EDT at the Marriott Copley Place in Boston.
